CJC-1295 + Ipamorelin (Blend)

Description

CJC (no DAC) + Ipamorelin is a research-grade blend combining two complementary GH axis peptides. CJC-1295 without Drug Affinity Complex is a GHRH analogue engaging the hypothalamic-pituitary axis at the GHRH receptor level. Ipamorelin is a selective GHSR-1a agonist engaging the ghrelin receptor pathway. In research settings, this combination is studied for its dual-mechanism GH axis engagement and associated downstream signaling.

BioRhex supplies CJC (no DAC) + Ipamorelin as a research compound manufactured in a GMP-compliant US facility, tested to ≥99% purity via HPLC and mass spectrometry, and supplied strictly for controlled laboratory research — not for human or animal use.